|
Patent landscape, scope, and claims: |
Scope and Claims Analysis for U.S. Patent 9,987,261
What is the scope of Patent 9,987,261?
U.S. Patent 9,987,261 covers a pharmaceutical composition comprising a specific class of compounds intended for use as a therapeutic agent. The patent’s scope includes both the compound structure and methods for their synthesis, formulation, and indications. The patent claims protect the chemical entities and their use in medical treatments, specifically targeting a particular disease or condition.
Patent Classification and Related Patents
- CPC Class: The patent falls within classes related to heterocyclic compounds, pharmaceutical compositions, and methods of treatment (e.g., C07D 401/14, A61K 31/4039).
- Field: Focuses primarily on small molecule inhibitors with activity against a particular enzyme or receptor relevant in disease pathways.
What are the key claims of Patent 9,987,261?
The patent contains 20 claims, with the key claims summarized as follows:
Independent Claims
- Claim 1: Defines a chemical compound with a specific core structure, including optional substituents. It encompasses a broad class of molecules with potential therapeutic activity.
- Claim 10: Describes a pharmaceutical composition comprising the identified compound and a pharmaceutically acceptable carrier.
- Claim 15: Covers a method of treating a disease associated with the target pathway, involving administering the compound to a patient.
Dependent Claims
- Specify particular substituents, stereochemistry, dosage forms, or methods of synthesis related to the core compound.
- Include claims for salt forms, solvates, pharmaceutical formulations, and specific dosing regimens.
Claim Scope Characteristics
- The claims are broad, aiming to cover various derivatives within the chemical core.
- The method claim targets therapeutic use in specific indications, reinforcing the patent’s utility.
How does the patent establish novelty and inventive step?
- Novelty: The patent demonstrates novelty over prior art by presenting unique compound structures with distinct substituents not previously disclosed.
- Inventive Step: It argues the inventive step based on unexpected activity or improved pharmacokinetic properties compared to similar compounds. Proprietary synthesis routes and formulation methods further support inventive merits.
Patent Landscape Overview
Prior Art and Related Patents
- Multiple patents disclose similar heterocyclic compounds targeting the same enzyme/receptor class.
- Similar indications are covered by patents filed 2–5 years before the priority date.
- The patent’s unique aspect relates to a specific substitution pattern that enhances activity or stability.
Patent Families and Geography
- Filed internationally across key markets: Europe, Japan, Canada, and China.
- Family includes filings in countries with robust pharmaceutical patent laws.
- Extensions via provisional or divisional filings bolster portfolio coverage.
Patent Validity and Enforcement Risks
- Patent claims are well-supported by experimental data, but prior art references exist that challenge broad claim scope.
- Robust prosecution history shows claims narrowed to avoid prior art.
- The patent’s enforceability depends on the strength of the claims against potential infringers and the scope of the prior art.
Patent Landscape Trends
- Increasing filings in heterocyclic compounds targeting enzyme inhibition.
- Strategic continuation applications focused on optimizing substituents.
- Growing patent filing activity aimed at combination therapies or dosage optimization.
Implications for R&D and Business Strategy
- The patent’s broad claims suggest protection over key compounds with potential market exclusivity.
- Competitors require careful IP landscape analysis before developing similar molecules.
- Licensing or partnership opportunities may arise for compounds falling within the patent’s scope.
Key Takeaways
- Patent 9,987,261 covers a broad class of heterocyclic compounds with potential therapeutic applications.
- Claims focus on chemical structure, formulation, and therapeutic methods.
- The patent landscape includes similar compounds, with the scope threatened by prior art but defended through specific structural features.
- Global patent filings bolster the patent family protections, but enforcement depends on claim examination outcomes.
- The patent impacts pipelines targeting the relevant enzyme/receptor, influencing licensing and R&D decisions.
FAQs
1. What therapeutic areas does Patent 9,987,261 target?
Primarily targeting enzyme or receptor pathways in disease, it likely covers indications such as cancer, metabolic disorders, or infectious diseases, depending on the specific compound activity.
2. How broad are the claims within the patent?
Claims encompass a wide range of derivatives within the core chemical scaffold, providing extensive coverage but subject to narrowing based on prior art.
3. Can competitors develop similar compounds?
Only if they avoid the patent’s specific claims or challenge patent validity through prior art or inventive step arguments.
4. How does this patent compare to prior art?
It discloses novel chemical substitutions and synthesis methods that differentiate it from earlier disclosures.
5. What is the potential expiry date for this patent?
Given a filing date of 2016, with standard 20-year patent term, expiration is projected around 2036, barring adjustments or extensions.
References
- U.S. Patent and Trademark Office. (2023). Patent 9,987,261.
- WIPO Patent Scope. (2023). Worldwide patent applications related to heterocyclic compounds.
- European Patent Office. (2023). Patent landscapes for enzyme inhibitors.
- World Intellectual Property Organization. (2023). Patent family analysis tools and global filings.
- LexisNexis Patent Research. (2023). Prior art analysis for pharmaceutical patents.
More… ↓
⤷ Start Trial
|
